FIELD: medicine; medical engineering.
SUBSTANCE: device has placental glycosaminglycans, glycerin, polyvinyl pyrrolidon, methyl cellulose, nipagin and purified water.
EFFECT: improved usability properties.
| Title | Year | Author | Number |
|---|---|---|---|
| OPHTHALMIC DROPS | 2002 |
|
RU2216331C1 |
| OPHTHALMIC OINTMENT | 1998 |
|
RU2168963C2 |
| OPHTHALMIC OINTMENT | 2007 |
|
RU2331408C1 |
| EYE DROPS | 1994 |
|
RU2088215C1 |
| EYEGEL | 1994 |
|
RU2098079C1 |
| BROAD ACTIVITY SPECTRUM MEANS FOR TREATING CUTANEOUS MYCOSES CASES | 2005 |
|
RU2292198C1 |
| EYE FILM | 1997 |
|
RU2173178C2 |
| OCULAR OINTMENT | 1994 |
|
RU2082434C1 |
| AGENT FOR SCABIES TREATMENT | 2001 |
|
RU2210365C1 |
| METHOD FOR PRODUCING OPHTHALMIC FILMS | 2004 |
|
RU2314793C2 |
Authors
Dates
2006-10-27—Published
2005-06-17—Filed